The social entrepreneurial organization Ashoka and pharmaceutical company Boehringer Ingelheim on Tuesday announced they are launching a three-year global initiative aimed at “promot[ing] healthy individuals, families and communities by identifying and supporting the most promising solutions to challenging health problems,” according to an Ashoka press release. The “Making More Health”…
Access to Health Services
Family planning “is one of the most cost-effective ways to prevent illness and save lives in the world’s poor countries,” according to health experts gathered in Addis Ababa, Ethiopia, at a conference sponsored by the Reproductive Health Supplies Coalition, GlobalPost’s “Africa Emerges” blog reports.
“Long heralded as a model for the global response to HIV/AIDS, Brazil is intensifying its actions, at home and abroad, in the face of potential setbacks including an arising need for new treatment regimens, the resultant increase in drug prices and the debate over intellectual property rights,” Inter Press Service…
GlobalPost on Sunday published two articles examining family planning and maternal mortality in Malawi.
“Cash-strapped Swaziland’s state hospitals have only two months’ supplies of AIDS drugs, the country’s health minister has told parliament in an assessment that AIDS patients and activists took as a death sentence,” the Associated Press/Seattle Times reports. More than 60,000 Swazis receive antiretroviral medicine at no cost from state-run hospitals.
In another installment in NPR’s summer-long series “Beginnings,” NPR’s All Things Considered aired a story on Wednesday examining how the controversial drug misoprostol is being used worldwide to save women’s lives.
With the global population expected to reach seven billion by October this year, U.N. Population Fund (UNFPA) Executive Director Babatunde Osotimehin told Inter Press Service that “seven billion represents a challenge, an opportunity and a call to action.”
“India will not compromise on drug licensing norms and [will] continue to produce generic drugs for free treatment to HIV-positive patients, Commerce and Industry Minister Anand Sharma said” on Wednesday, the IANS/Times of India reports.
“In the first agreement between a pharmaceutical company and the new international Medicines Patent Pool, Gilead Sciences announced Tuesday that it would license four of its AIDS and hepatitis B drugs to the pool,” the New York Times reports (McNeil, 7/12).
Health ministers from Brazil, Russia, India, China, and South Africa in Beijing “on Monday vowed to improve access to low-cost and high-quality medicine â€“ and called on developed nations to shoulder responsibility in helping the poor,” Agence France-Presse reports (7/11).